Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Stimulus Package Creates Flurry of Research Funds

Kurt Ullman  |  Issue: October 2009  |  October 1, 2009

Dr. Carter acknowledges that this is an X-factor in the ARRA process. “We say thanks to Congress for allowing us to do something really special, but there is no question that there may be problems two years from now.”

Nevertheless, rheumatology researchers are making good use of the ARRA funds to launch new research projects, support ongoing investigations, and create partnerships and consortia to further understanding of rheumatic disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Kurt Ullman is a freelance writer based in Indiana.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:Basic researchClinical researchLegislationNational Institutes of HealthNIH

Related Articles

    National Institute of Arthritis & Musculoskeletal & Skin Diseases Report for 2015

    January 1, 2015

    NIAMS director Stephen I. Katz, MD, PhD, highlights agency research, training planned for this year and beyond

    Gorodenkoff / shutterstock.com

    The NIAMS Diversity Supplement Program Offers Researcher Funding

    January 10, 2022

    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, as well as the training of basic and clinical scientists to carry out this research. NIAMS recognizes the…

    NIAMS’ Intramural Research Programs Foster Spirit of Discovery

    March 1, 2015

    National Institute of Arthritis and Musculoskeletal and Skin Diseases program recognized for excellence in training, innovation

    Research Across the Spectrum

    September 1, 2009

    NIAMS director highlights innovative research initiatives

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences